Showing results (91-100 of 109) with videos related to

Sort By:
Pageof 11
Chest|June 6, 2022
Drug-Related Pneumonitis Induced by Osimertinib as First-Line Treatment for Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer: A Real-World SettingYuki Sato, Hiromitsu Sumikawa, Ryota Shibaki, et al.
Lung Cancer (Amsterdam, Netherlands)|May 25, 2025
Investigation of cardiotoxicity in patients treated with osimertinib: findings from the OSI-FACT studyAsuka Okada, Yoshihiko Sakata, Yuko Oya, et al.
European Journal of Cancer (Oxford, England : 1990)|November 8, 2021
Osimertinib as first-line treatment for advanced epidermal growth factor receptor mutation-positive non-small-cell lung cancer in a real-world setting (OSI-FACT)Yoshihiko Sakata, Shinya Sakata, Yuko Oya, et al.
European Journal of Cancer (Oxford, England : 1990)|December 5, 2022
Safety and efficacy of osimertinib rechallenge or continuation after pneumonitis: A multicentre retrospective cohort studyMihoko Imaji, Daichi Fujimoto, Yuki Sato, et al.
JCO Oncology Practice|November 8, 2022
Most Important Things and Associated Factors With Prioritizing Daily Life in Patients With Advanced Lung CancerNaofumi Kameyama, Takashi Sato, Daisuke Arai, et al.
International Journal of Clinical Oncology|November 5, 2025
Lung immune prognostic index as a biomarker for predicting the benefit of immune checkpoint inhibitor plus chemotherapy in older patients with non-small cell lung cancer: a secondary analysis of the NEJ057 studyTakehiro Tozuka, Yoko Tsukita, Kohei Kushiro, et al.
Lung Cancer (Amsterdam, Netherlands)|August 11, 2022
Real-world outcomes of chemotherapy for lung cancer patients undergoing hemodialysis: A multicenter retrospective cohort study (NEJ-042)Yuji Minegishi, Tomoe Akagami, Makoto Arai, et al.
Molecular and Clinical Oncology|April 29, 2017
Erlotinib as second- or third-line treatment in elderly patients with advanced non-small cell lung cancer: Keio Lung Oncology Group Study 001 (KLOG001)Masayoshi Miyawaki, Katsuhiko Naoki, Satoshi Yoda, et al.
Palliative Medicine|March 25, 2021
Trends of concerns from diagnosis in patients with advanced lung cancer and their family caregivers: A 2-year longitudinal studyTakashi Sato, Daisuke Fujisawa, Daisuke Arai, et al.
The Oncologist|August 19, 2018
Prognostic Understanding at Diagnosis and Associated Factors in Patients with Advanced Lung Cancer and Their CaregiversTakashi Sato, Kenzo Soejima, Daisuke Fujisawa, et al.
Pageof 11